Cutavirus DNA in Malignant and Nonmalignant Skin of Cutaneous T-Cell Lymphoma and Organ Transplant Patients but Not of Healthy Adults

• Published in: Clinical infectious diseases Vol. 68; no. 11; pp. 1904 - 1910
• Main Authors: Väisänen, Elina, Fu, Yu, Koskenmies, Sari, Fyhrquist, Nanna, Wang, Yilin, Keinonen, Anne, Mäkisalo, Heikki, Väkevä, Liisa, Pitkänen, Sari, Ranki, Annamari, Hedman, Klaus, Söderlund-Venermo, Maria
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 17.05.2019
• Subjects: ARTICLES AND COMMENTARIES; skin; protoparvovirus; cancer; parvovirus; disease association
• ISSN: 1058-4838; 1537-6591; 1537-6591
• DOI: 10.1093/cid/ciy806

Abstract Background Three new parvoviruses of Protoparvovirus genus, bufavirus (BuV), tusavirus (TuV), and cutavirus (CuV), have recently been discovered in diarrheal stools. CuV was further detected in a proportion of cutaneous T-cell lymphoma (CTCL)/mycosis fungoides skin samples and in one melanoma. Patients and Methods With novel multiplex quantitative polymerase chain reaction and antibody assays, we studied 3 patient groups for BuV, TuV, and CuV DNA and immunoglobulin G (IgG): CTCL patients, immunosuppressed solid-organ transplant recipients, and immunocompetent healthy adults. Results CuV DNA was detected in skin biopsies of 4/25 (16.0%) CTCL and 4/136 (2.9%) transplant patients but not in any of 159 skin samples of 98 healthy adults. The dermal CuV-DNA prevalence was significantly higher in CTCL patients than in the other subjects. CuV DNA was further detected in healthy skin of 4 organ transplant recipients, 2 of whom also had CuV-positive skin carcinomas. One CTCL patient harbored CuV DNA in both malignant (CTCL, melanoma) and nonmalignant skin and sentinel lymph nodes but not in his prostate. The CuV IgG seroprevalences were among CTCL patients 9.5% (4/42), transplant recipients 6.5% (8/124), and healthy adults 3.8% (3/78). BuV and TuV DNAs were absent and antibodies infrequent in all cohorts. Parvoviral antibodies were shown to persist for ≥20 years and dermal CuV DNA for 4 years. All 3 CuV-DNA-positive patients, with both biopsies and sera available, were CuV-IgG positive. Conclusion Our results suggest that dermal CuV DNA carriage is associated with CTCL. Any putative roles of CuV in the carcinogenesis must be determined in forthcoming studies. This study revealed a significantly higher human cutavirus DNA prevalence in the skin of cutaneous T-cell lymphoma patients, compared to organ transplant recipients and healthy adults. This suggests that dermal CuV DNA is significantly associated with CTCL.